Naples Global Advisors LLC Lowers Holdings in Dolby Laboratories $DLB

Key Points

• Naples Global Advisors LLC reduced its stake in Dolby Laboratories by 10.9%, owning 31,495 shares worth approximately $2.34 million after selling 3,835 shares during the second quarter.
• Dolby's stock has had a slight decline of 0.2%, currently opening at $72.22, with a market cap of $6.92 billion and a P/E ratio of 26.45.
• Insiders sold a total of 99,366 shares valued at over $7.29 million in the last ninety days, decreasing their ownership stake to 38.39%.

Naples Global Advisors LLC decreased its stake in Dolby Laboratories (NYSE:DLB - Free Report) by 10.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,495 shares of the electronics maker's stock after selling 3,835 shares during the quarter. Naples Global Advisors LLC's holdings in Dolby Laboratories were worth $2,339,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. Securian Asset Management Inc. lifted its position in shares of Dolby Laboratories by 3.0% in the first quarter. Securian Asset Management Inc. now owns 4,648 shares of the electronics maker's stock valued at $373,000 after acquiring an additional 137 shares in the last quarter. MAI Capital Management lifted its position in shares of Dolby Laboratories by 87.1% in the first quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock valued at $28,000 after acquiring an additional 162 shares in the last quarter. Net Worth Advisory Group lifted its position in shares of Dolby Laboratories by 5.2% in the first quarter. Net Worth Advisory Group now owns 3,591 shares of the electronics maker's stock valued at $288,000 after acquiring an additional 178 shares in the last quarter. US Bancorp DE lifted its position in shares of Dolby Laboratories by 18.6% in the first quarter. US Bancorp DE now owns 1,444 shares of the electronics maker's stock valued at $116,000 after acquiring an additional 226 shares in the last quarter. Finally, Linden Thomas Advisory Services LLC lifted its position in shares of Dolby Laboratories by 2.7% in the first quarter. Linden Thomas Advisory Services LLC now owns 8,635 shares of the electronics maker's stock valued at $693,000 after acquiring an additional 229 shares in the last quarter. Hedge funds and other institutional investors own 58.56% of the company's stock.

Insiders Place Their Bets

In other news, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares of the company's stock, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Kevin J. Yeaman sold 25,000 shares of Dolby Laboratories stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $71.66, for a total value of $1,791,500.00. Following the completion of the sale, the chief executive officer directly owned 114,725 shares of the company's stock, valued at $8,221,193.50. The trade was a 17.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 99,366 shares of company stock valued at $7,293,963 over the last ninety days. Insiders own 38.39% of the company's stock.

Dolby Laboratories Stock Down 0.2%

NYSE:DLB opened at $72.22 on Thursday. Dolby Laboratories has a 52 week low of $68.24 and a 52 week high of $89.66. The company has a market capitalization of $6.92 billion, a P/E ratio of 26.45 and a beta of 0.92. The stock's fifty day moving average is $72.84 and its two-hundred day moving average is $74.67.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its earnings results on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The company had revenue of $315.55 million for the quarter, compared to the consensus estimate of $305.23 million. During the same quarter in the previous year, the business earned $0.71 earnings per share. The company's revenue for the quarter was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Sell-side analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th were paid a $0.33 dividend. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. Dolby Laboratories's payout ratio is presently 48.35%.

Wall Street Analysts Forecast Growth

DLB has been the subject of several recent research reports. Baird R W raised Dolby Laboratories to a "hold" rating in a report on Friday, September 5th. Rosenblatt Securities reaffirmed a "buy" rating and issued a $95.00 price target on shares of Dolby Laboratories in a report on Friday, August 1st. Wall Street Zen raised Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Robert W. Baird initiated coverage on Dolby Laboratories in a report on Friday, September 5th. They issued a "neutral" rating and a $74.00 price target for the company. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Friday, September 12th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Dolby Laboratories currently has a consensus rating of "Moderate Buy" and an average price target of $95.75.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.